Pharma M&A versus alliances and its underlying value drivers Image close
Pharma M&A versus alliances and its underlying value drivers on Hardback by Heiko Schon
Pharma M&A versus alliances and its underlying value drivers on Hardback by Heiko Schon
Show Hide Adult Content
Pharma M&A versus alliances and its underlying value drivers close

Business & Economics Books:

Home  
Books  
Business & Economics  
Economics  
Economic theory & philosophy

Pharma M&A versus alliances and its underlying value drivers

Are M&A or alliances the right therapy for an ailing pharmaceutical industry?- A capital market perspective
Click to share your rating 0 ratings (0.0/5.0 average) Thanks for your vote!

By:

Format:

Hardback
$223.00
Available from supplier

The item is brand new and in-stock with one of our preferred suppliers. The item will ship from a Mighty Ape warehouse within the timeframe shown.

Usually ships in 3-4 weeks
0 in Trolley
Free Delivery with Primate
Join Now

Free 14 day free trial, cancel anytime.

Buy Now, Pay Later with:

4 payments of $55.75 with Afterpay Learn more

6 weekly interest-free payments of $37.17 with Laybuy Learn more

Availability

Delivering to:

Estimated arrival:

  • Around 25 Jun - 5 Jul using International Courier

Explore more Corporate Finance and Governance

See all products in this series

Analyzing Wealth Effects for Bondholders by Daniel Maul
$223.00
Analyzing Wealth Effects for Bondholders
by Daniel Maul ~ Paperback / softback
Available - Usually ships in 3-4 weeks
Bank mergers and acquisitions in the Asia-Pacific region by Sascha Kolaric
$203.00
Bank mergers and acquisitions in the Asia-Pacific region
by Sascha Kolaric ~ Paperback / softback
Available - Usually ships in 3-4 weeks
Financial Return Risk and the Effect on Shareholder Wealth on Hardback by Malte Raudszus
$223.00
Financial Return Risk and the Effect on Shareholder Wealth
by Malte Raudszus ~ Hardback
Available - Usually ships in 3-4 weeks
Risk-Adjusted Performance and Bank Governance Structures on Hardback by Christoph Bohm
$223.00
Risk-Adjusted Performance and Bank Governance Structures
by Christoph Bohm ~ Hardback
Available - Usually ships in 3-4 weeks
Mergers and Acquisitions in the Energy Sector on Hardback by Robert Fraunhoffer
$162.00
Mergers and Acquisitions in the Energy Sector
by Robert Fraunhoffer ~ Hardback
Available - Usually ships in 3-4 weeks
Minority Shareholder Monitoring and German Corporate Governance on Hardback by Christian Thamm
$129.00
Minority Shareholder Monitoring and German Corporate Governance
by Christian Thamm ~ Hardback
Available - Usually ships in 3-4 weeks
Creating and Governing an Integrated Market for Retail Banking Services in Europe on Hardback by Matthaus Markus Sielecki
$277.00
Creating and Governing an Integrated Market for Retail Banking...
by Matthaus Markus Sielecki ~ Hardback
Available - Usually ships in 3-4 weeks
Bank Governance Structures and Risk Taking by Dennis Froneberg
$223.00
Bank Governance Structures and Risk Taking
by Dennis Froneberg ~ Paperback / softback
Available - Usually ships in 3-4 weeks
Valuation and Value Creation of Insurance Intermediaries on Hardback by Claudia Max
$311.00
Valuation and Value Creation of Insurance Intermediaries
by Claudia Max ~ Hardback
Available - Usually ships in 3-4 weeks

Description

From a capital market perspective, the author analyzes Merger and Acquisitions transactions (M&A) and in-licensings in the pharmaceutical industry between 1998 and 2012. Utilizing the event study methodology, the volume shows that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. But what are the underlying value drivers which make a deal a success or a failure story? The author derives significant innovative determinants of success for both strategies.

Author Biography:

Heiko Schön studied international business administration at Wiesbaden Business School. He was scholar of the German National Merit Foundation (sdw), he owns an Executive MBA from the University of Münster and earned his PhD at the University of Darmstadt. He brings in 10 years of experience in the pharmaceutical and chemical industry.
Release date NZ
September 28th, 2015
Author
Audience
  • Professional & Vocational
Contributor
  • Series edited by Dirk Schiereck
Edition
New edition
Pages
201
ISBN-13
9783631663813
Product ID
24145270

Customer reviews

Nobody has reviewed this product yet. You could be the first!

Write a Review

Marketplace listings

There are no Marketplace listings available for this product currently.
Already own it? Create a free listing and pay just 9% commission when it sells!

Sell Yours Here

Recommended for you

Recommended from your browsing history

Help & options

Filed under...

Books >
Business & Economics >
Economics >
Economic theory & philosophy
Books >
Business & Economics >
Business & Management
Books >
Business & Economics >
Business & Management >
Ownership & Organisation >
Multinationals
Books >
Business & Economics >
Business & Management >
Management Techniques
Books >
Business & Economics >
Business & Management >
Management Techniques >
Organizational theory & behaviour
Books >
Non-Fiction >
Professional & Technical >
Medicine >
Medicine: general issues